Literature DB >> 27551252

Management of the Acid Pocket.

Peter J Kahrilas1.   

Abstract

Year:  2014        PMID： 27551252      PMCID： PMC4991534     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period.

Authors:  W O Rohof; R J Bennink; A A de Ruigh; D P Hirsch; A H Zwinderman; G E Boeckxstaens
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

2.  Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.

Authors:  A De Ruigh; S Roman; J Chen; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2014-07-10       Impact factor: 8.171

Review 3.  The acid pocket: a target for treatment in reflux disease?

Authors:  Peter J Kahrilas; Kenneth McColl; Mark Fox; Lisa O'Rourke; Daniel Sifrim; Andre J P M Smout; Guy Boeckxstaens
Journal:  Am J Gastroenterol       Date:  2013-04-30       Impact factor: 10.864

4.  An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.

Authors:  M A Kwiatek; S Roman; A Fareeduddin; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

5.  Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach.

Authors:  Wout O Rohof; Roelof J Bennink; Guy E Boeckxstaens
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-12       Impact factor: 11.382

6.  Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.

Authors:  E Thomas; A Wade; G Crawford; B Jenner; N Levinson; J Wilkinson
Journal:  Aliment Pharmacol Ther       Date:  2014-01-28       Impact factor: 8.171

7.  An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.

Authors:  Wout O Rohof; Roel J Bennink; Andre J P M Smout; Edward Thomas; Guy E Boeckxstaens
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.